Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort (2021)

First Author: Handy A

Attributed to: Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.09.03.21263023

Publication URI: http://dx.doi.org/10.1101/2021.09.03.21263023

Type: Preprint